GPCR/G protein
All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-
B6872 IRL-2500Target: ETA Receptors|ETB ReceptorsSummary: endothelin receptor antagonist
-
B5070 Sarafotoxin S6cSummary: Highly selective ETB endothelin receptor agonist
-
B5079 IRL-1038Summary: ETB endothelin receptor antagonist
-
B5080 [Ala1,3,11,15]-EndothelinSummary: Selective ETB endothelin receptor agonist